Weekly Docetaxel and CMF in the Adjuvant Treatment of Elderly Women With High-Risk Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Docetaxel|DRUG: Cyclophosphamide|DRUG: Methotrexate|DRUG: 5-Fluorouracil
Sponsor: SCRI Development Innovations, LLC
Collaborators: Aventis Pharmaceuticals